Volume 22, Number 12—December 2016
Letter
Pathogenic Lineage of mcr-Negative Colistin-Resistant Escherichia coli, Japan, 2008–2015
Table
Strain | Specimen type | Patient age, y/sex | Year | Serotype | ST | MIC, mg/L† |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PIP | CAZ | CPD | FEP | IPM | GEN | AMK | CIP | CST | PMB | ||||||
SRE34 |
Urine catheter |
UNK/F |
2008 |
O25b:H4 |
131-
H30Rx |
128 (R) |
1
(S) |
1
(S) |
0.06 (S) |
0.125 (S) |
0.5 (S) |
2
(S) |
32 (R) |
16 (R), 16 (R)‡ |
8,
8‡ |
SRE44 |
Urine catheter |
UNK/M |
2008 |
O25b:H4 |
131-
H30Rx |
64 (R) |
2
(S) |
1
(S) |
0.13
(S) |
0.25 (S) |
0.5 (S) |
1
(S) |
64 (R) |
16 (R), 16 (R)‡ |
16,
8‡ |
SME222 |
Indwelling pericardial drain |
76/M |
2015 |
O18 |
416 |
2
(S) |
0.5 (S) |
0.5 (S) |
<0.03 (S) |
0.13 (S) |
0.5 (S) |
2
(S) |
0.03 (S) |
4 (R),
4 (R)‡ |
8,
4‡ |
SME296 | Urine | 67/M | 2015 | O25b:H4 | 131- H30R | >128 (R) | 32 (R) | >128 (R) | 16 (R) | 0.13 (S) | 0.5 (S) | 2 (S) | 64 (R) | 4 (R), 8 (R)‡ | 1, 4‡ |
*All isolates were phylogentic group B2. AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CPD, cefpodoxime; FEP, cefepime; CST, colistin; GEN, gentamicin; IPM, imipenem; PIP, piperacillin; PMB, polymyxin B; R, resistant; S, susceptible; ST, sequence type; UNK, unknown.
†EUCAST (http://www.eucast.org/) breakpoints were used for resistance determination because the colistin breakpoint for E. coli was undetermined by the Clinical and Laboratory Standards Institute. MICs were determined by the agar dilution method unless otherwise stated. Breakpoints: PIP, >16; CAZ, >16; CPD, >1; FEP, >4; IPM, >8; GEN, >4; AMK, >16; CIP, >1; CST, >2.
‡Broth microdilution method.
Page created: November 18, 2016
Page updated: November 18, 2016
Page reviewed: November 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.